Health

Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B

BRII-179 (VBI-2601) as an add-on therapy to standard of care PEG-IFNα increases HBsAg loss rate at the end of treatment and 12 weeks follow up Significantly increased HBsAg seroconversion rate is strongly associated with BRII-179 treatment and correlates with the increased rate of HBsAg loss Saf...

2023-09-06 18:45 2437

Cell Impact participates in the Stuttgart hy-fcell conference and exhibition

KARLSKOGA, Sweden, Sept. 6, 2023 /PRNewswire/ -- Cell Impact participates in hy-fcell inStuttgart, Germany, one of the world's largest and most important hydrogen technology industry events. Cell Impact will present the company's flow plate production offer based on the unique forming technology ...

2023-09-06 16:55 2175

Alma welcomes the iconic Hollywood superstar, Kate Hudson as its new Global Brand Ambassador

* The long-term partnership aims to emphasize the empowerment of natural beauty, with Alma committed to delivering safe, effective, and evidence-based solutions. * The actress and entrepreneur will be featured in a brand-new campaign themed "Beyond the Trend," highlighting reliable aesthetic ...

2023-09-06 15:24 2337

HEALTH INNOVATIONS ACQUIRES ASKDR, A SINGAPORE-BASED DIGITAL HEALTH START-UP

SINGAPORE, Sept. 6, 2023 /PRNewswire/ -- Health Innovations, a consortium of practising medical doctors from GP+ cooperative, is pleased to announce its acquisition of AskDr , a leading digital ...

2023-09-06 15:15 2226

Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM

MELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company's theranostic programs at the 36th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held inVienna from 9...

2023-09-06 14:18 1702

Zimmer Biomet India Launches Zimmer Biomet on Wheels Campaign

NEW DELHI, Sept. 6, 2023 /PRNewswire/ -- Zimmer Biomet India today announced the launch of the Zimmer Biomet on Wheels campaign, a mobile vehicle housing the company's innovative products and solutions, including Knee, Hips, Shoulder, and Sports Medicine product portfolios that leverage data, ana...

2023-09-06 11:30 2388

MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study

GENEVA, Sept. 6, 2023 /PRNewswire/ -- The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which is where ...

2023-09-06 08:00 1847

Infinitus Showcases Its Health Food Brand Oriherb at the China Quality Conference in Chengdu

GUANGZHOU, China, Sept. 6, 2023 /PRNewswire/ -- Co-hosted by the State Administration for Market Regulation, the People's Government ofSichuan Province and the Chengdu Municipal People's Government, the 5th China Quality Conference took place inChengdu, Sichuan province on September 1-3. Infinitu...

2023-09-06 08:00 1869

iHerb Celebrates 27 Years of Quality and Announces Historic Anniversary Sale

Leading health and wellness eCommerce store celebrates another year of accomplishments fueled by its "quality first" foundation to its products, customers, and employees, offering daily deep discounts for a limited time IRVINE, Calif., Sept. 6, 2023 /PRNewswire/ -- iHerb proudly announces its 27...

2023-09-06 02:55 2334

MALAYSIA HEALTHCARE TRAVEL COUNCIL SELECTS MAYO CLINIC TO PROVIDE STRATEGIC COUNSEL TO FURTHER ADVANCE MEDICAL EXCELLENCE IN MALAYSIA

PUTRAJAYA, Malaysia, Sept. 5, 2023 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC), an agency established under the purview of Ministry of Health Malaysia, has officially announced the successful establishment of a Memorandum of Understanding (MoU) with US-basedMayo Clinic

2023-09-05 22:37 2141

SIBIONICS Launches the Breakthrough SIBIO KS1 CKM for Ketone Level Monitoring

SHENZHEN, China, Sept. 5, 2023 /PRNewswire/ -- SIBIONICS, a leader in bio-wearable consumer electronics, is pleased to announce the launch of SIBIO KS1 Continuous Ketone Monitoring (CKM) System, the company's newest biometric wearable device designed to measure ketone levels. Boasting CE certific...

2023-09-05 21:56 2817

YS Biopharma to Participate in Citi's 18th Annual Biopharma Conference

GAITHERSBURG, Md., Sept. 5, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious di...

2023-09-05 20:30 1638

"AIA Creator Fund" to Provide a Total of HK$5 Million in Support of Youth-driven Social Innovation Projects

HONG KONG, Sept. 5, 2023 /PRNewswire/ -- AIA Hong Kong has announced the launch of the "AIA Creator Fund", an initiative that will provide a total ofHK$5 million in funding as well as guidance and support for young people to carry out social innovation projects for the betterment of the community...

2023-09-05 16:29 2255

CIGNA HEALTHCARE LAUNCHES NEW GLOBAL HEALTH BENEFITS PLAN FOR ADULTS AGED 60+

* Bespoke solution designed to meet growing consumer demand for international health coverage * Includes full cancer coverage and benefits to support health and well-being across all areas of life * Includes optional outpatient cover for certain chronic conditions, including type 2 diabetes...

2023-09-05 15:00 1794

European Wellness and Heidelberg University Revolutionize Down Syndrome Research, Moving into Neurodevelopmental and Neurodegenerative Studies

HEIDELBERG, Germany, Sept. 5, 2023 /PRNewswire/ -- A ground-breaking research collaboration between European Wellness Biomedical Group (EWBG), through its subsidiaries European Wellness Academy (EWA) and Baden R&D Laboratories (Baden), and Heidelberg's Institute of Anatomy and Cell Biology has yi...

2023-09-05 14:06 2225

Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise

LYNGE, Denmark, Sept. 5, 2023 /PRNewswire/ -- Hearing aid innovator Signia, part of WS Audiology, today launchesIntegrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns t...

2023-09-05 14:00 1536

ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001

*  Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform *  ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data *  ACM is in partnering d...

2023-09-05 14:00 1714

Toolkit of family friendly policy options to help APAC countries reverse collapsing birth rates

ADELAIDE, Australia, Sept. 5, 2023 /PRNewswire/ -- Academic, medical and public sector experts across theAsia Pacific region have contributed to an innovative toolkit designed to guide policy makers in addressing social and economic challenges associated with free-falling birth rates in APAC coun...

2023-09-05 13:25 1515

Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare

* The report shows digital health technologies demonstrate value, yet integrating them into care systems remains challenging. Involving healthcare professionals and patients in technology design and development is also critical for patient-centred care.1 * The report surveyed 10 countries, al...

2023-09-05 13:00 4063

First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventional VAD

SUZHOU, China, Sept. 5, 2023 /PRNewswire/ -- Recently, NyokAssist™ was first-in-man (FIM) use, supporting High-risk PCI completed by Dr. Junbo Ge's team from Zhongshan Hospital inShanghai. This successful implementation of HRPCI initially confirmed the safety and effectiveness of NyokAssist™ in ...

2023-09-05 12:53 1531
1 ... 126127128129130131132 ... 581